IDEAS home Printed from https://ideas.repec.org/a/epw/ejmed0/v4y2022i3id41325.html

Aterm Pregnant Women with Human Immunodeficiency Virus Infection Which Receive Antiretroviral Therapy Combination of Nucleoside Analogue Reverse Transcriptase Inhibitor as A Risk Factor of High Expression of Apoptosis Including Factors

Author

Listed:
  • I Gusti Made Kusuma Widnyana

    (Sanglah General Hospital, Indonesia)

  • I Wayan Artana Putra

    (Sanglah General Hospital, Indonesia)

  • Tjokorda G. A. Suwardewa

    (Sanglah General Hospital, Indonesia)

  • Putu Doster Mahayasa

    (Sanglah General Hospital, Indonesia)

  • I Made Darmayasa

    (Sanglah General Hospital, Indonesia)

  • I Gde Sastra Winata

    (Sanglah General Hospital, Indonesia)

Abstract

Aim: To determine whether term pregnant women with human immunodeficiency virus infection who received antiretroviral therapy had high apoptosis inducing factor expression in the placenta. Methods: This cross-sectional analytical study was conducted at Sanglah General Hospital, Denpasar, and educational network hospitals. Subjects collected were termed pregnant women with HIV (+) who received antiretroviral therapy (ART) 6 months as a risk group and pregnant women with HIV (-) as a non-risk group. AIF expression was assessed by immunohistochemical examination of placental tissue. The AIF expression cut-off value was determined by constructing a receiver operating characteristics (ROC) curve. The chi-square test assessed the difference in proportion by displaying the prevalence ratio (RP) results. The significance of this study was p

Suggested Citation

  • I Gusti Made Kusuma Widnyana & I Wayan Artana Putra & Tjokorda G. A. Suwardewa & Putu Doster Mahayasa & I Made Darmayasa & I Gde Sastra Winata, 2022. "Aterm Pregnant Women with Human Immunodeficiency Virus Infection Which Receive Antiretroviral Therapy Combination of Nucleoside Analogue Reverse Transcriptase Inhibitor as A Risk Factor of High Expression of Apoptosis Including Factors," European Journal of Medical and Health Sciences, European Open Science, vol. 4(3), pages 38-41, May.
    • Handle: RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41325
    DOI: 10.24018/ejmed.2022.4.3.1325
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/ejmed/article/view/41325
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/ejmed/article/download/41325/9481
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/ejmed.2022.4.3.1325?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41325. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.